Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Anti-CTLA-4 Antibody in Advanced Synovial Sarcoma Patients

NCT00140855 is registered in ClinicalTrials.gov with Ludwig Institute for Cancer Research as lead sponsor.

NCT NCT00140855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Anti-CTLA-4 Antibody in Advanced Synovial Sarcoma Patients
Lead sponsor
Ludwig Institute for Cancer Research
Phase
Phase 2
Overall status
Terminated
Start date
June 8, 2005
Completion date
July 1, 2007
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

synovial sarcoma